KDOQI clinical practice guideline for nutrition in CKD: 2020 update
TA Ikizler, JD Burrowes, LD Byham-Gray… - American Journal of …, 2020 - Elsevier
Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for nutrition in kidney diseases since …
(KDOQI) has provided evidence-based guidelines for nutrition in kidney diseases since …
Stirring the pot: can dietary modification alleviate the burden of CKD?
Diet is one of the largest modifiable risk factors for chronic kidney disease (CKD)-related
death and disability. CKD is largely a progressive disease; however, it is increasingly …
death and disability. CKD is largely a progressive disease; however, it is increasingly …
[PDF][PDF] Dietary fat modification in patients with chronic kidney disease: n-3 fatty acids and beyond
Replacement of dietary saturated fat with unsaturated fat has been recommended for
prevention of cardiovascular disease (CVD) in the general population. Less is known of the …
prevention of cardiovascular disease (CVD) in the general population. Less is known of the …
[HTML][HTML] Role of some functional lipids in preventing diseases and promoting health
B Alabdulkarim, ZAN Bakeet, S Arzoo - Journal of King Saud University …, 2012 - Elsevier
Fats and lipids are common components of food and may perform essential roles. Their
types may be more important with regard to health and disease than their amount. The …
types may be more important with regard to health and disease than their amount. The …
Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients
H Tayyebi-Khosroshahi, J Houshyar… - Saudi Journal of …, 2012 - journals.lww.com
Abstract C-reactive protein (CRP), a strong independent risk marker of cardiovascular
disease (CVD), and tumor necrosis factor-alfa (TNF-α), a known pro-inflammatory cytokine …
disease (CVD), and tumor necrosis factor-alfa (TNF-α), a known pro-inflammatory cytokine …
Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients
AE Naini, N Keyvandarian, M Mortazavi… - Journal of research in …, 2015 - journals.lww.com
Objective: Hypertension and hyperlipidemia are two major risk factors for cardiovascular
disease in continuous ambulatory peritoneal dialysis (CAPD) patients. This study was …
disease in continuous ambulatory peritoneal dialysis (CAPD) patients. This study was …
Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients
A Kooshki, FA Taleban, H Tabibi, M Hedayati - Renal failure, 2011 - Taylor & Francis
Background: Lipid abnormalities, especially high serum lipoprotein (a)[Lp (a)] concentration,
and anemia are two major causes of cardiovascular diseases (CVDs) in hemodialysis …
and anemia are two major causes of cardiovascular diseases (CVDs) in hemodialysis …
Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis
T Xu, Y Sun, W Sun, L Yao, L Sun, L Liu, J Ma… - Scientific reports, 2016 - nature.com
Abstract Omega-3 fatty acids (O3FAs) are associated with lower cardiovascular disease
(CVD) risk in adults. However, this association in patients with end-stage renal disease …
(CVD) risk in adults. However, this association in patients with end-stage renal disease …
Effects of fish oil on serum lipid profile in dialysis patients: a systematic review and meta-analysis of randomized controlled trials
W Zhu, C Dong, H Du, H Zhang, J Chen, X Hu… - Lipids in health and …, 2014 - Springer
Background The effects of fish oil supplements on lipid profile in dialysis patients are
controversial. With increasing interest in the potential health benefits of fish oil, it is important …
controversial. With increasing interest in the potential health benefits of fish oil, it is important …
[PDF][PDF] Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients
H Tayebi-Khosroshahi, R Dehgan, BH Asl… - Iranian journal of kidney …, 2013 - sid.ir
Materials and Methods. In a randomized controlled trial, 100 hemodialysis patients were
assigned into two groups to receive omega-3 (oral capsule, 3 g/d) or placebo for 2 months …
assigned into two groups to receive omega-3 (oral capsule, 3 g/d) or placebo for 2 months …